Literature DB >> 7470941

Biochemical characterization of solubilized muscarinic acetylcholine receptors.

H Repke, H Matthies.   

Abstract

Several in part new methods (salt extraction, phospholipase treatment, transfer to serumlipoproteins, nonionic detergent mixtures) have been extensively examined in order to obtain a solubilized muscarinic acetylcholine receptor with properties suitable for further purification. An optimal mixture of digitonin and gitonin has been found which forms a tightly bound detergent wall around the receptor protein as indicated by ion exchange and monolayer studies and which allows to solubilize the receptor from enriched synaptosomal membranes with a high yield and stability. The specific 3H-QNB binding of this preparation is nearly unchanged between pH 7.5 and 10. The isoelectric point of the muscarinic acetylcholine receptor has been determined by isoelectric focusing to be between pH 4.5 and 4.6.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7470941     DOI: 10.1016/0361-9230(80)90209-9

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  4 in total

1.  Solubilization and characterization of guanine nucleotide-sensitive muscarinic agonist binding sites from rat myocardium.

Authors:  C P Berrie; N J Birdsall; E C Hulme; M Keen; J M Stockton
Journal:  Br J Pharmacol       Date:  1984-08       Impact factor: 8.739

2.  Solubilization and hydrodynamic properties of pig atrial muscarinic acetylcholine receptor in dodecyl beta-D-maltoside.

Authors:  G L Peterson; L C Rosenbaum; M I Schimerlik
Journal:  Biochem J       Date:  1988-10-15       Impact factor: 3.857

3.  Monoclonal antibodies against the native or denatured forms of muscarinic acetylcholine receptors.

Authors:  C André; J G Guillet; J P De Backer; P Vanderheyden; J Hoebeke; A D Strosberg
Journal:  EMBO J       Date:  1984-01       Impact factor: 11.598

4.  Purification of muscarinic acetylcholine receptors by affinity chromatography.

Authors:  C André; J P De Backer; J C Guillet; P Vanderheyden; G Vauquelin; A D Strosberg
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.